Summary
The target concentration strategy has proved a valuable approach for dose individualisation, giving proper weight to the high interindividual variation in plasma concentrations. Nevertheless, optimisation of plasma concentrations does not necessarily yield optimal pharmacodynamic effects because variability in the plasma concentration-effect relationship is far from insignificant. We argue that this is due not only to unpredictable target tissue sensitivity but also to a highly variable, and equally unpredictable, distribution process from plasma into the interstitial space of the target tissue, the true effect compartment. This is borne out by recent results from studies employing modern techniques that enable direct measurement of target tissue drug concentrations, like magnetic resonance spectroscopy, single photon emission computed tomography, and tissue microdialysis. Such forthcoming results highlight the importance of the distribution process as a key factor determining drug response. Clinical pharmacology should seek an improved understanding of the biological determinants governing not only plasma but tissue drug concentrations.
Similar content being viewed by others
References
Sheiner LB, Tozer TN. Clinical pharmacokinetics: the use of plasma concentrations of drugs. In: Melmon KL, Morelli HF, editors. Clinical pharmacology: basic principles of therapeutics. New York: Macmillan, 1978: 71–109.
Peck CC. Reply: Concentration-controlled versus concentration-defined trials. Clin Pharmacol Ther. 1993; 53: 385–7.
Holford HG. The target concentration approach to clinical drug development. Clin Pharmacokinet. 1995; 29(5): 287–91.
Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharmacol Ther. 1997; 61(3): 275–91.
Padrini R, Piovan D, Busa M, et al. Pharmacodynamic variability of flecainide assessed by QRS changes. Clin Pharmacol Ther. 1993; 53: 59–64.
Michel CC. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol (Lond). 1980; 309: 341–55.
Curry FE. Determinants of capillary permeability: a review of mechanisms based on single capillary studies in the frog. Circ Res. 1986; 59: 367–80.
Beck RB, Schultz JS. Hindrance of solute diffusion with membranes as measured with membranes of knownpore geometry. Biochim Biophys Acta. 1972; 255: 273–303.
Renkin EM. Multiple pathways of capillary permeability. Circ Res. 1997; 41: 735–43.
Renkin EM. Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol. 1985; 58: 315–25.
Müller M, Holmäng A, Andersson O, et al. Measurement of interstitial muscle glucose and lactate during an oral glucose tolerance test. Am J Physiol. 1996; 271: E1003–7.
Lönnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol. 1987; 16: E228–31.
Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987; 47: 3039–51.
Derendorf H, Hochhaus G, editors. Pharmacokinetic/pharmacodynamic correlation. Boca Raton: CRC Press, 1995.
Müller M, Mader RM, Steiner B, et al. 5-Fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res. 1997; 57: 2598–601.
Bertazzoni Minelli E, Benini A, Muner A, et al. Pefloxacin penetration into human pancreatic tissue. J Antimicrob Agents Chemother. 1996; 38: 237–43.
Front D, Israel O, Iosilevsky G, et al. Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake. Radiology. 1987; 165: 129–33.
Jynge P, Skjetne T, Gribbestad I, et al. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther. 1990; 48: 481–9.
Müller M, Haag O, Burgdorff T, et al. Characterization of peripheral compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother. 1996; 40(12): 2703–9.
Pujol JL, Cupissol D, Gestin-Boyer C, et al. Tumor-tissue and plasma concentrations of platinum during chemotherapy of non small cell lung cancer patients. Cancer Chemother Pharmacol. 1990; 27: 72–5.
Blöchl-Daum B, Müller M, Meisinger V, et al. Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis. Br J Cancer. 1996; 73: 920–4.
Geny F, Costa P, Bressolle F, Galtier M. Ceftriaxone pharmacokinetics in elderly subjects and penetration into epididymis. Biopharm Drug Dispos. 1993; 14(2): 161–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eichler, HG., Müller, M. Drug Distribution. Clin Pharmacokinet 34, 95–99 (1998). https://doi.org/10.2165/00003088-199834020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199834020-00001